The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Akouos, Inc | COMM | 00973J101 | 21,014 | 1,515,074 | SH | SOLE | 1,515,074 | 0 | 0 | ||
Amarin Corp | ADR | 023111206 | 7,269 | 1,170,584 | SH | SOLE | 1,170,584 | 0 | 0 | ||
Ascendis Pharma A/S | ADR | 04351P101 | 67,265 | 521,923 | SH | SOLE | 521,923 | 0 | 0 | ||
Athira Pharma, Inc. | COMM | 04746L104 | 9,369 | 509,168 | SH | SOLE | 509,168 | 0 | 0 | ||
Bolt Biotherapeutics, Inc. | COMM | 097702104 | 90,649 | 2,754,437 | SH | SOLE | 2,754,437 | 0 | 0 | ||
Checkmate Pharmaceuticals Inc | COMM | 162818108 | 43,785 | 3,606,707 | SH | SOLE | 3,606,707 | 0 | 0 | ||
Coherus BioSciences | COMM | 19249H103 | 6,349 | 434,555 | SH | SOLE | 434,555 | 0 | 0 | ||
Galera Therapeutics, Inc | COMM | 36338D108 | 27,198 | 3,083,712 | SH | SOLE | 3,083,712 | 0 | 0 | ||
Inozyme Pharma, Inc. | COMM | 45790W108 | 40,160 | 2,028,308 | SH | SOLE | 2,028,308 | 0 | 0 | ||
Karuna Therapeutics, Inc. | COMM | 48576A100 | 234,742 | 1,952,441 | SH | SOLE | 1,952,441 | 0 | 0 | ||
Merus N.V. | COMM | N5749R100 | 27,388 | 1,311,039 | SH | SOLE | 1,311,039 | 0 | 0 | ||
Natera | COMM | 632307104 | 314,831 | 3,100,560 | SH | SOLE | 3,100,560 | 0 | 0 | ||
Nextcure, Inc | COMM | 65343E108 | 26,745 | 2,671,856 | SH | SOLE | 2,671,856 | 0 | 0 | ||
Nucana Biomed Ltd | ADR | 67022C106 | 27,944 | 5,599,999 | SH | SOLE | 5,599,999 | 0 | 0 | ||
Nucana Biomed Ltd | Ordinary Shares | GB00BYWYV | 11,976 | 2,400,000 | SH | SOLE | 2,400,000 | 0 | 0 | ||
ObsEva SA | COMM | H5861P103 | 15,436 | 4,749,623 | SH | SOLE | 4,749,623 | 0 | 0 | ||
PDS Biotechnology Corporation | COMM | 70465T107 | 649 | 142,635 | SH | SOLE | 142,635 | 0 | 0 | ||
Synlogic Inc. | COMM | 87166L100 | 2,058 | 574,972 | SH | SOLE | 574,972 | 0 | 0 | ||
Y-mAbs Therapeutics, Inc | COMM | 984241109 | 66,355 | 2,194,278 | SH | SOLE | 2,194,278 | 0 | 0 | ||
Acceleron Pharma Inc | COMM | 00434H108 | 24,212 | 178,538 | SH | SOLE | 178,538 | 0 | 0 | ||
Agenus Inc | COMM | 00847G705 | 9,461 | 3,478,201 | SH | SOLE | 3,478,201 | 0 | 0 | ||
Align Technology Inc | COMM | 016255101 | 24,640 | 45,500 | SH | SOLE | 45,500 | 0 | 0 | ||
Aligos Therapeutics Inc | COMM | 01626L105 | 4,219 | 185,532 | SH | SOLE | 185,532 | 0 | 0 | ||
Amgen Inc | COMM | 031162100 | 9,671 | 38,868 | SH | SOLE | 38,868 | 0 | 0 | ||
Aptose Biosciences Inc | COMM | 03835T200 | 4,164 | 696,928 | SH | SOLE | 696,928 | 0 | 0 | ||
Arena Pharmaceuticals Inc | COMM | 040047607 | 6,346 | 91,448 | SH | SOLE | 91,448 | 0 | 0 | ||
AstraZeneca PLC | ADR | 046353108 | 51,497 | 1,035,732 | SH | SOLE | 1,035,732 | 0 | 0 | ||
BioCryst Pharmaceuticals Inc | COMM | 09058V103 | 3,852 | 378,774 | SH | SOLE | 378,774 | 0 | 0 | ||
Calithera Biosciences Inc | COMM | 13089P101 | 1,833 | 757,533 | SH | SOLE | 757,533 | 0 | 0 | ||
ChemoCentryx Inc | COMM | 16383L956 | 7,686 | 150,000 | SH | Put | SOLE | 150,000 | 0 | 0 | |
ChemoCentryx Inc | COMM | 16383L106 | 9,223 | 179,999 | SH | SOLE | 179,999 | 0 | 0 | ||
Cytokinetics Inc | COMM | 23282W605 | 9,065 | 389,720 | SH | SOLE | 389,720 | 0 | 0 | ||
Dexcom Inc | COMM | 252131107 | 9,704 | 27,000 | SH | SOLE | 27,000 | 0 | 0 | ||
Eli Lilly and Co | COMM | 532457108 | 33,721 | 180,501 | SH | SOLE | 180,501 | 0 | 0 | ||
Exelixis Inc | COMM | 30161Q104 | 18,957 | 839,181 | SH | SOLE | 839,181 | 0 | 0 | ||
Fate Therapeutics Inc | COMM | 31189P102 | 4,518 | 54,795 | SH | SOLE | 54,795 | 0 | 0 | ||
Gilead Sciences Inc | COMM | 375558903 | 19,389 | 300,000 | SH | Call | SOLE | 300,000 | 0 | 0 | |
Health Care Select Sector SPDR | COMM | 81369Y959 | 46,696 | 400,000 | SH | Put | SOLE | 400,000 | 0 | 0 | |
Heron Therapeutics Inc | COMM | 427746902 | 4,053 | 250,000 | SH | Call | SOLE | 250,000 | 0 | 0 | |
Horizon Therapeutics PLC | COMM | G46188101 | 12,333 | 133,997 | SH | SOLE | 133,997 | 0 | 0 | ||
Immatics NV | COMM | N44445109 | 4,317 | 385,099 | SH | SOLE | 385,099 | 0 | 0 | ||
Insmed Inc | COMM | 457669307 | 21,081 | 618,950 | SH | SOLE | 618,950 | 0 | 0 | ||
Insulet Corp | COMM | 45784P101 | 4,566 | 17,500 | SH | SOLE | 17,500 | 0 | 0 | ||
Intra-Cellular Therapies Inc | COMM | 46116X101 | 22,224 | 655,001 | SH | SOLE | 655,001 | 0 | 0 | ||
Jazz Pharmaceuticals PLC | COMM | G50871105 | 42,067 | 255,928 | SH | SOLE | 255,928 | 0 | 0 | ||
Jounce Therapeutics Inc | COMM | 481116101 | 5,256 | 511,822 | SH | SOLE | 511,822 | 0 | 0 | ||
Kura Oncology Inc | COMM | 50127T109 | 2,351 | 83,164 | SH | SOLE | 83,164 | 0 | 0 | ||
MacroGenics Inc | COMM | 556099109 | 2,331 | 73,201 | SH | SOLE | 73,201 | 0 | 0 | ||
Marinus Pharmaceuticals Inc | COMM | 56854Q200 | 5,733 | 370,351 | SH | SOLE | 370,351 | 0 | 0 | ||
Mirati Therapeutics Inc | COMM | 60468T105 | 23,645 | 138,030 | SH | SOLE | 138,030 | 0 | 0 | ||
Mirum Pharmaceuticals Inc | COMM | 604749101 | 9,442 | 476,401 | SH | SOLE | 476,401 | 0 | 0 | ||
Otonomy Inc | COMM | 68906L105 | 3,191 | 1,251,256 | SH | SOLE | 1,251,256 | 0 | 0 | ||
PTC Therapeutics Inc | COMM | 69366J200 | 22,105 | 466,840 | SH | SOLE | 466,840 | 0 | 0 | ||
Protagonist Therapeutics Inc | COMM | 74366E102 | 16,962 | 654,900 | SH | SOLE | 654,900 | 0 | 0 | ||
Puma Biotechnology Inc | COMM | 74587V107 | 3,353 | 344,917 | SH | SOLE | 344,917 | 0 | 0 | ||
Reata Pharmaceuticals Inc | COMM | 75615P103 | 23,780 | 238,520 | SH | SOLE | 238,520 | 0 | 0 | ||
Regenxbio Inc | COMM | 75901B107 | 12,339 | 361,735 | SH | SOLE | 361,735 | 0 | 0 | ||
Replimune Group Inc | COMM | 76029N106 | 4,339 | 142,209 | SH | SOLE | 142,209 | 0 | 0 | ||
Savara Inc | COMM | 805111101 | 3,614 | 1,737,450 | SH | SOLE | 1,737,450 | 0 | 0 | ||
Syndax Pharmaceuticals Inc | COMM | 87164F105 | 6,678 | 298,644 | SH | SOLE | 298,644 | 0 | 0 | ||
TCR2 Therapeutics Inc | COMM | 87808K106 | 7,434 | 336,682 | SH | SOLE | 336,682 | 0 | 0 | ||
Uniqure NV | COMM | N90064101 | 14,390 | 427,122 | SH | SOLE | 427,122 | 0 | 0 | ||
United Therapeutics Corp | COMM | 91307C102 | 35,972 | 215,054 | SH | SOLE | 215,054 | 0 | 0 | ||
Vertex Pharmaceuticals Inc | COMM | 92532F100 | 9,820 | 45,700 | SH | SOLE | 45,700 | 0 | 0 |